Latest Privium Fund Management B.V. Stock Portfolio
Privium Fund Management B.V. Performance:
2025 Q3: 19.15%YTD: 16.9%2024: 18.57%
Performance for 2025 Q3 is 19.15%, and YTD is 16.9%, and 2024 is 18.57%.
About Privium Fund Management B.V. and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Privium Fund Management B.V. reported an equity portfolio of $556.3 Millions as of 30 Sep, 2025.
The top stock holdings of Privium Fund Management B.V. are TSLA, , . The fund has invested 19.5% of it's portfolio in TESLA INC and 11.9% of portfolio in SPOTIFY TECHNOLOGY S A.
The fund managers got completely rid off CARVANA CO (CVNA), SAREPTA THERAPEUTICS INC (SRPT) and EMX RTY CORP stocks. They significantly reduced their stock positions in MODERNA INC (MRNA), ACADIA PHARMACEUTICALS INC (ACAD) and PALANTIR TECHNOLOGIES INC (PLTR). Privium Fund Management B.V. opened new stock positions in ADVANCED MICRO DEVICES INC (AMD), LEMONADE INC (LMND) and IREN LIMITED. The fund showed a lot of confidence in some stocks as they added substantially to FATE THERAPEUTICS INC (FATE), BIOGEN INC (BIIB) and UROGEN PHARMA LTD (URGN).
The top stock holdings of Privium Fund Management B.V. are TSLA, , . The fund has invested 19.5% of it's portfolio in TESLA INC and 11.9% of portfolio in SPOTIFY TECHNOLOGY S A.
The fund managers got completely rid off CARVANA CO (CVNA), SAREPTA THERAPEUTICS INC (SRPT) and EMX RTY CORP stocks. They significantly reduced their stock positions in MODERNA INC (MRNA), ACADIA PHARMACEUTICALS INC (ACAD) and PALANTIR TECHNOLOGIES INC (PLTR). Privium Fund Management B.V. opened new stock positions in ADVANCED MICRO DEVICES INC (AMD), LEMONADE INC (LMND) and IREN LIMITED. The fund showed a lot of confidence in some stocks as they added substantially to FATE THERAPEUTICS INC (FATE), BIOGEN INC (BIIB) and UROGEN PHARMA LTD (URGN).
Privium Fund Management B.V. Annual Return Estimates Vs S&P 500
Our best estimate is that Privium Fund Management B.V. made a return of 19.15% in the last quarter. In trailing 12 months, it's portfolio return was 33.6%.
New Buys
| Ticker | $ Bought |
|---|---|
| advanced micro devices inc | 9,707,400 |
| lemonade inc | 7,761,850 |
| iren limited | 6,100,900 |
| ast spacemobile inc | 5,398,800 |
| abivax sa | 2,581,980 |
| beam therapeutics inc | 1,480,470 |
| schlumberger ltd | 676,986 |
| transocean ltd | 318,240 |
New stocks bought by Privium Fund Management B.V.
Additions
| Ticker | % Inc. |
|---|---|
| fate therapeutics inc | 199 |
| biogen inc | 153 |
| urogen pharma ltd | 82.7 |
| hims & hers health inc | 81.82 |
| voyager therapeutics inc | 78.28 |
| biontech se | 72.93 |
| sandridge energy inc | 36.11 |
| krystal biotech inc | 30.58 |
Additions to existing portfolio by Privium Fund Management B.V.
Reductions
| Ticker | % Reduced |
|---|---|
| moderna inc | -54.56 |
| acadia pharmaceuticals inc | -52.56 |
| palantir technologies inc | -42.86 |
| valaris ltd | -39.76 |
| pan amern silver corp | -37.7 |
| sprott fds tr | -29.67 |
| sea ltd | -23.81 |
| sibanye stillwater ltd | -22.94 |
Privium Fund Management B.V. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| emx rty corp | -544,590 |
| sarepta therapeutics inc | -697,774 |
| dyne therapeutics inc | -239,273 |
| carvana co | -1,684,800 |
Privium Fund Management B.V. got rid off the above stocks
Sector Distribution
Privium Fund Management B.V. has about 33.3% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 33.3 |
| Consumer Cyclical | 25.4 |
| Healthcare | 22.2 |
| Technology | 12 |
| Financial Services | 6.2 |
Market Cap. Distribution
Privium Fund Management B.V. has about 45.4% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 33.4 |
| MEGA-CAP | 30.8 |
| LARGE-CAP | 14.6 |
| MID-CAP | 11.5 |
| SMALL-CAP | 9.6 |
Stocks belong to which Index?
About 44.8% of the stocks held by Privium Fund Management B.V. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 55.2 |
| S&P 500 | 33.2 |
| RUSSELL 2000 | 11.6 |
Privium Fund Management B.V. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Privium Fund Management B.V.
Privium Fund Management B.V. has 59 stocks in it's portfolio. About 74.8% of the portfolio is in top 10 stocks. RARE proved to be the most loss making stock for the portfolio. TSLA was the most profitable stock for Privium Fund Management B.V. last quarter.
Last Reported on: 04 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACAD | acadia pharmaceuticals inc | 0.27 | 70,400 | 1,502,340 | reduced | -52.56 | ||
| ALXO | alx oncology hldgs inc | 0.17 | 509,059 | 931,578 | unchanged | 0.00 | ||
| AMD | advanced micro devices inc | 1.75 | 60,000 | 9,707,400 | new | |||
| AMZN | amazon com inc | 5.88 | 149,000 | 32,715,900 | unchanged | 0.00 | ||
| ARQT | arcutis biotherapeutics inc | 1.04 | 305,972 | 5,767,570 | reduced | -11.18 | ||
| ARWR | arrowhead pharmaceuticals in | 2.94 | 473,951 | 16,346,600 | reduced | -22.58 | ||
| ASTS | ast spacemobile inc | 0.97 | 110,000 | 5,398,800 | new | |||
| AUTL | autolus therapeutics plc | 0.09 | 308,837 | 503,404 | added | 5.00 | ||
| AXSM | axsome therapeutics inc | 1.15 | 52,732 | 6,404,300 | unchanged | 0.00 | ||
| BEAM | beam therapeutics inc | 0.27 | 61,000 | 1,480,470 | new | |||
| BIIB | biogen inc | 1.31 | 51,925 | 7,273,650 | added | 153 | ||
| COIN | coinbase global inc | 4.79 | 79,000 | 26,661,700 | added | 12.86 | ||
| CRSP | crispr therapeutics ag | 0.47 | 40,000 | 2,592,400 | reduced | -10.51 | ||
| CVNA | carvana co | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DYN | dyne therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| FATE | fate therapeutics inc | 0.07 | 333,219 | 419,856 | added | 199 | ||
| FDMT | 4d molecular therapeutics in | 0.31 | 197,458 | 1,715,910 | unchanged | 0.00 | ||
| HIMS | hims & hers health inc | 0.41 | 40,000 | 2,268,800 | added | 81.82 | ||
| IONS | ionis pharmaceuticals inc | 2.93 | 248,894 | 16,282,600 | reduced | -6.99 | ||
| KRYS | krystal biotech inc | 0.39 | 12,170 | 2,148,370 | added | 30.58 | ||